Swiperx Secures Us$27 Million In Series B Funding To Accelerate Growth Across Southeast Asia
May 23, 2022•about 3 years ago
Amount Raised
$27 Million
Round Type
series b
Description
SwipeRx (formerly mClinica Pharmacy Solutions), Southeast Asia's (SEA) leading platform for pharmacies, announced it has secured a Series B round of US$27 million in equity and debt to accelerate growth across SEA. The round was led by Indonesia's MDI Ventures, with participation from global investors, Bill & Melinda Gates Foundation, Johnson & Johnson Impact Ventures, SIG and existing investors.
FundzWatch™ Score
65
Medium Activity
Buyer Intent Analysis
Get personalized insights on buying likelihood
Funding Insights
Based on industry dataTech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech